{"id":12935,"date":"2016-03-09T19:17:50","date_gmt":"2016-03-10T00:17:50","guid":{"rendered":"http:\/\/goldstocksforex.com\/?p=12935"},"modified":"2016-03-09T19:17:50","modified_gmt":"2016-03-10T00:17:50","slug":"weekly-investment-commentary-from-bob-doll-nuveen-investments","status":"publish","type":"post","link":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/","title":{"rendered":"Bob Doll: It May Take Better News for the Rally to Continue"},"content":{"rendered":"

\"Bob<\/p>\n

From Bob Doll at Nuveen Investments:<\/p>\n

It May Take Better News for the Rally to Continue<\/p>\n

Financial markets appear to be normalizing in recent weeks after the risk asset rout that started the year. We would caution, however, that market improvements have come about because the news has become less bad, not because it has turned good. Investor sentiment is fragile and will likely remain so for some time. One of the key variables remains oil prices. Oil markets have stabilized in recent weeks, but volatility and a renewed downturn could occur anytime. We also believe we need a sustained improvement in U.S. and Chinese economic data before investors grow more confident. Finally, the global political system remains a wildcard. The current focus is on the possibility of the United Kingdom leaving the European Union. The odds favor the status quo, but a potential \u201cbrexit\u201d would be destabilizing for the U.K., and the uncertainty is fueling downward pressure on risk assets.<\/p><\/blockquote>\n

I agree with Bob’s view that a broad US recession is unlikely. Energy and Materials sectors are contracting but the rest of the market has so far held up well. But I am concerned that profit margins are falling and sales growth is slowing — which could lead to weaker stock prices. <\/p>\n

Shrinking bank net interest margins and a flattening yield curve both warn of a future credit contraction, however, that would make recession highly likely. Based on past (reactive rather than proactive) performance by the Fed we cannot expect swift action to avoid this threat.<\/p>\n

Source: Weekly Investment Commentary from Bob Doll | Nuveen Investments<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

From Bob Doll at Nuveen Investments: It May Take Better News for the Rally to Continue Financial markets appear to be normalizing in recent weeks after the risk asset rout that started the year. We would caution, however, that market improvements have come about because the news has become less bad, not because it has … <\/p>\n

Continue reading “Bob Doll: It May Take Better News for the Rally to Continue”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[57],"tags":[],"class_list":["post-12935","post","type-post","status-publish","format-standard","hentry","category-stock-markets"],"yoast_head":"\nBob Doll: It May Take Better News for the Rally to Continue - the patient investor<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bob Doll: It May Take Better News for the Rally to Continue - the patient investor\" \/>\n<meta property=\"og:description\" content=\"From Bob Doll at Nuveen Investments: It May Take Better News for the Rally to Continue Financial markets appear to be normalizing in recent weeks after the risk asset rout that started the year. We would caution, however, that market improvements have come about because the news has become less bad, not because it has … Continue reading "Bob Doll: It May Take Better News for the Rally to Continue"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/\" \/>\n<meta property=\"og:site_name\" content=\"the patient investor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61572934660810\" \/>\n<meta property=\"article:published_time\" content=\"2016-03-10T00:17:50+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/03\/bob_doll_december_2015_market_update.jpg\" \/>\n<meta name=\"author\" content=\"ColinTwiggs\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"ColinTwiggs\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/\"},\"author\":{\"name\":\"ColinTwiggs\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/cb072791ac83e8bae585007c133d54a5\"},\"headline\":\"Bob Doll: It May Take Better News for the Rally to Continue\",\"datePublished\":\"2016-03-10T00:17:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/\"},\"wordCount\":280,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2016\\\/03\\\/bob_doll_december_2015_market_update.jpg\",\"articleSection\":[\"Stock Markets\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/\",\"name\":\"Bob Doll: It May Take Better News for the Rally to Continue - the patient investor\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2016\\\/03\\\/bob_doll_december_2015_market_update.jpg\",\"datePublished\":\"2016-03-10T00:17:50+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2016\\\/03\\\/bob_doll_december_2015_market_update.jpg?fit=130%2C80&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2016\\\/03\\\/bob_doll_december_2015_market_update.jpg?fit=130%2C80&ssl=1\",\"width\":130,\"height\":80},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/2016\\\/03\\\/09\\\/weekly-investment-commentary-from-bob-doll-nuveen-investments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/thepatientinvestor.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bob Doll: It May Take Better News for the Rally to Continue\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#website\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"name\":\"The Patient Investor\",\"description\":\"Smart. Strategic. Unfiltered. \",\"publisher\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/thepatientinvestor.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#organization\",\"name\":\"The Patient Investor Pty Ltd\",\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/thepatientinvestor.com\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1\",\"width\":250,\"height\":250,\"caption\":\"The Patient Investor Pty Ltd\"},\"image\":{\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61572934660810\",\"https:\\\/\\\/www.instagram.com\\\/colin_thepatientinvestor\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/thepatientinvestor.com\\\/#\\\/schema\\\/person\\\/cb072791ac83e8bae585007c133d54a5\",\"name\":\"ColinTwiggs\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g\",\"caption\":\"ColinTwiggs\"},\"url\":\"https:\\\/\\\/thepatientinvestor.com\\\/index.php\\\/author\\\/colin58s\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bob Doll: It May Take Better News for the Rally to Continue - the patient investor","robots":{"index":"noindex","follow":"follow"},"og_locale":"en_US","og_type":"article","og_title":"Bob Doll: It May Take Better News for the Rally to Continue - the patient investor","og_description":"From Bob Doll at Nuveen Investments: It May Take Better News for the Rally to Continue Financial markets appear to be normalizing in recent weeks after the risk asset rout that started the year. We would caution, however, that market improvements have come about because the news has become less bad, not because it has … Continue reading \"Bob Doll: It May Take Better News for the Rally to Continue\"","og_url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/","og_site_name":"the patient investor","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61572934660810","article_published_time":"2016-03-10T00:17:50+00:00","og_image":[{"url":"http:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/03\/bob_doll_december_2015_market_update.jpg","type":"","width":"","height":""}],"author":"ColinTwiggs","twitter_card":"summary_large_image","twitter_misc":{"Written by":"ColinTwiggs","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/#article","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/"},"author":{"name":"ColinTwiggs","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5"},"headline":"Bob Doll: It May Take Better News for the Rally to Continue","datePublished":"2016-03-10T00:17:50+00:00","mainEntityOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/"},"wordCount":280,"commentCount":0,"publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/#primaryimage"},"thumbnailUrl":"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/03\/bob_doll_december_2015_market_update.jpg","articleSection":["Stock Markets"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/","url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/","name":"Bob Doll: It May Take Better News for the Rally to Continue - the patient investor","isPartOf":{"@id":"https:\/\/thepatientinvestor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/#primaryimage"},"image":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/#primaryimage"},"thumbnailUrl":"https:\/\/thepatientinvestor.com\/wp-content\/uploads\/2016\/03\/bob_doll_december_2015_market_update.jpg","datePublished":"2016-03-10T00:17:50+00:00","breadcrumb":{"@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/#primaryimage","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2016\/03\/bob_doll_december_2015_market_update.jpg?fit=130%2C80&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2016\/03\/bob_doll_december_2015_market_update.jpg?fit=130%2C80&ssl=1","width":130,"height":80},{"@type":"BreadcrumbList","@id":"https:\/\/thepatientinvestor.com\/index.php\/2016\/03\/09\/weekly-investment-commentary-from-bob-doll-nuveen-investments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/thepatientinvestor.com\/"},{"@type":"ListItem","position":2,"name":"Bob Doll: It May Take Better News for the Rally to Continue"}]},{"@type":"WebSite","@id":"https:\/\/thepatientinvestor.com\/#website","url":"https:\/\/thepatientinvestor.com\/","name":"The Patient Investor","description":"Smart. Strategic. Unfiltered. ","publisher":{"@id":"https:\/\/thepatientinvestor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/thepatientinvestor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/thepatientinvestor.com\/#organization","name":"The Patient Investor Pty Ltd","url":"https:\/\/thepatientinvestor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/","url":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","contentUrl":"https:\/\/i0.wp.com\/thepatientinvestor.com\/wp-content\/uploads\/2026\/03\/cropped-cropped-patience-bg-1-inverted-400x400-1.png?fit=250%2C250&ssl=1","width":250,"height":250,"caption":"The Patient Investor Pty Ltd"},"image":{"@id":"https:\/\/thepatientinvestor.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61572934660810","https:\/\/www.instagram.com\/colin_thepatientinvestor"]},{"@type":"Person","@id":"https:\/\/thepatientinvestor.com\/#\/schema\/person\/cb072791ac83e8bae585007c133d54a5","name":"ColinTwiggs","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/876c4d990bb2af282291d5f3ff81533c6deccc0c607846086647ca3272fac0ca?s=96&d=mm&r=g","caption":"ColinTwiggs"},"url":"https:\/\/thepatientinvestor.com\/index.php\/author\/colin58s\/"}]}},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p9tQ4n-3mD","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":22136,"url":"https:\/\/thepatientinvestor.com\/index.php\/2020\/10\/19\/bob-doll-equity-market-resiliency-may-be-tested\/","url_meta":{"origin":12935,"position":0},"title":"Bob Doll: Equity market resiliency may be tested","author":"Colin Twiggs","date":"October 19, 2020","format":false,"excerpt":"From Bob Doll at Nuveen Investments: \"Equity markets are caught between hopes for a better economic future and signs that the coronavirus pandemic is worsening and economic momentum may be fading. At this point, the pace of the recovery is clearly slowing, and policymakers are running out of options to\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14448,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/11\/07\/equity-prices-falter-in-advance-of-the-elections-bob-doll\/","url_meta":{"origin":12935,"position":1},"title":"Equity Prices Falter in Advance of the Elections | Bob Doll","author":"ColinTwiggs","date":"November 7, 2016","format":false,"excerpt":"From Bob Doll at Nuveen: ....we think it is more likely than not that Hillary Clinton will be elected president. Regardless of voters\u2019 opinions, Clinton\u2019s policies would be more predictable than those of Donald Trump, and if there is one thing that financial markets like, it is predictability. If we\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":14360,"url":"https:\/\/thepatientinvestor.com\/index.php\/2016\/10\/17\/weekly-investment-commentary-from-bob-doll-nuveen\/","url_meta":{"origin":12935,"position":2},"title":"Weekly Investment Commentary from Bob Doll | Nuveen","author":"ColinTwiggs","date":"October 17, 2016","format":false,"excerpt":"From Bob Doll: Equities may struggle until corporate earnings improve. For the past 18 months, equities have been able to make modest gains despite declining corporate profits. This has largely been due to highly accommodative monetary policy and central banks\u2019 willingness to engage in new easing measures. Additionally, investors have\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":15617,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/07\/21\/weekly-top-themes-from-bob-doll-nuveen\/","url_meta":{"origin":12935,"position":3},"title":"Weekly Top Themes from Bob Doll | Nuveen","author":"ColinTwiggs","date":"July 21, 2017","format":false,"excerpt":"U.S. monetary policy should remain equity-market friendly. In her comments last week, Janet Yellen stated that the neutral rate for the fed funds rate is \u201ccurrently quite low,\u201d and rates would not have to rise much more to become neutral. In our view, a neutral fed funds rate is closer\u2026","rel":"","context":"In "Banks & Interest Rates"","block_context":{"text":"Banks & Interest Rates","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/economy\/the-fed-banks-interest-rates\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":15370,"url":"https:\/\/thepatientinvestor.com\/index.php\/2017\/05\/30\/weekly-investment-commentary-from-bob-doll-nuveen-2\/","url_meta":{"origin":12935,"position":4},"title":"Weekly Investment Commentary from Bob Doll | Nuveen","author":"ColinTwiggs","date":"May 30, 2017","format":false,"excerpt":"Key points from Bob Doll's weekly investment summary: We believe U.S. economic growth should rebound in the second quarter and corporate earnings will remain solid. Investors remain uneasy about global macro conditions, but we believe the backdrop remains supportive for equities. We may be seeing a transition in global equity\u2026","rel":"","context":"In "Stock Markets"","block_context":{"text":"Stock Markets","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/stock-markets\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":16252,"url":"https:\/\/thepatientinvestor.com\/index.php\/2018\/05\/07\/bob-doll-first-quarter-earnings-continue-to-impress\/","url_meta":{"origin":12935,"position":5},"title":"Bob Doll: First quarter earnings continue to impress","author":"Colin Twiggs","date":"May 7, 2018","format":false,"excerpt":"More positive news on earnings from Bob Doll's weekly newsletter: .....2. First quarter earnings results continue to impress, helped by tax cuts. With 85% of companies reporting, earnings are ahead of expectations by an average of 7.3%.1 Earnings-per-share growth is on track for 25%.1 Were it not for the effects\u2026","rel":"","context":"In "Earnings & Dividends"","block_context":{"text":"Earnings & Dividends","link":"https:\/\/thepatientinvestor.com\/index.php\/category\/investing\/earnings-dividends\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"_links":{"self":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/12935","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/comments?post=12935"}],"version-history":[{"count":0,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/posts\/12935\/revisions"}],"wp:attachment":[{"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/media?parent=12935"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/categories?post=12935"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thepatientinvestor.com\/index.php\/wp-json\/wp\/v2\/tags?post=12935"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}